Cooke & Bieler LP Has $146.14 Million Position in Teleflex Incorporated (NYSE:TFX)

Cooke & Bieler LP lessened its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 1.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,057,528 shares of the medical technology company's stock after selling 21,029 shares during the quarter. Teleflex makes up about 1.5% of Cooke & Bieler LP's holdings, making the stock its 24th largest position. Cooke & Bieler LP owned 2.28% of Teleflex worth $146,140,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Headlands Technologies LLC purchased a new stake in Teleflex in the 4th quarter valued at approximately $29,000. MassMutual Private Wealth & Trust FSB lifted its position in shares of Teleflex by 103.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 100 shares during the period. Whipplewood Advisors LLC lifted its position in shares of Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock valued at $32,000 after acquiring an additional 231 shares during the period. Allworth Financial LP lifted its position in shares of Teleflex by 504.8% during the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock valued at $34,000 after acquiring an additional 212 shares during the period. Finally, True Wealth Design LLC lifted its position in shares of Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock valued at $48,000 after acquiring an additional 104 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Stock Up 0.3%

Teleflex stock traded up $0.38 during trading on Thursday, reaching $113.70. 543,589 shares of the company's stock were exchanged, compared to its average volume of 636,597. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28. The company's 50-day moving average is $121.24 and its two-hundred day moving average is $142.41. The firm has a market cap of $5.02 billion, a price-to-earnings ratio of 35.87, a PEG ratio of 1.78 and a beta of 1.08. Teleflex Incorporated has a 52-week low of $112.32 and a 52-week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The company's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the company posted $3.21 earnings per share. On average, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.20%. The ex-dividend date was Tuesday, May 20th. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

Analyst Ratings Changes

A number of research firms have recently issued reports on TFX. Morgan Stanley reduced their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Mizuho cut their price objective on Teleflex from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Wednesday. Royal Bank Of Canada set a $130.00 price objective on Teleflex and gave the stock a "sector perform" rating in a research report on Tuesday. Wall Street Zen downgraded Teleflex from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Finally, Truist Financial cut their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research report on Monday, May 5th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Teleflex presently has a consensus rating of "Hold" and a consensus target price of $159.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.